About AllThingsLifeSciences/CleanTech: 2010
The Springboard: AllThingsLIfeSciences/CleanTech: 2010 program featured 20 of the most promising high-growth, women-led companies in biotech, biopharma, health IT, healthcare, medical devices, and diagnostics. The Forum was held in June, 2010 in Boston, MA showcasing the entrepreneurs before an audience of the area’s top corporate, angel, and venture investors.
Supporting Organizations
Forum Committees
Investor Committee
Jack Ahrens, TGap Ventures
Jahanara Ali, NYC Investment Fund
Richard Anders, Mass Medical Angels (MA2)
Ben Auspitz, Fidelity Biosciences
Elizabeth Bailey, Commons Capital
Kevin Bitterman, Polaris Venture Partners
Dan Broderick, BioGenerator
Mike Bunker, Early Stage Partners
James Burgum, Arthur Ventures
Christian Cortis, ATV Capital
Ann Dewitt, Flagship Ventures
Cynthia Doerr, Essex Woodlands Health Ventures
Ted Driscoll, Claremont Creek Ventures
Suzette Dutch, Triathlon Medical Ventures
Stuart Eckmann, Life Science Angels
Teresa Esser, Capital Midwest Fund
Pete Farner, TGap Ventures
Lauren Flanagan, Phenomenelle Angels
Nancy Floyd, Nth Power
Jennifer Friel Goldstein, Pfizer Inc
Andrew Friendly, ATV Capital
Jan Garfinkle, Arboretum Ventures
Karen Hong, ProQuest Investments
Eva Jack, Medimmune Ventures
Elaine Jones, Pfizer, Inc.
Kef Kasdin, Battelle Ventures
Stephen Kraus, Bessemer Venture Partners
Ron Lennox, CHL Medical Partners
Reid Leonard, Merck & Co, Inc.
Debra Liebel, Domain Associates
Ellen Lubman, Bristol-Meyers Squibb
Michael Lytton, Biogen Idec
Carol Marino, Syngenta Venture Capital
Michael Melnick, CMEA Capital
Dan Meyer, Point Judith Capital
Pat Morand, SMLS Venture Fund
Todd Morrill, Bio-Rad Laboratories
Dana Ono, VIMAC Ventures LLC
Catherine Oyler, Johnson & Johnson
William Paiva, Sevin Rosen Funds
Ann Partlow, Earthrise Capital
Pooja Pathak, Oxford Bioscience Partners
Susan Rohrer, Merck & Co, Inc.
Amita Shukla, New Enterprise Associates
Lauren Silverman, Novartis Venture Capital
Karen Spilizewski, RiverVest Venture Partners
Richard Stuebi, Early Stage Partners
Geeta Vemuri, BioVentures
Tracy Warren, Battelle Ventures
Yael Weiss, Merck & Co, Inc.
Alex Zisson, Thomas McNerney & Partners
Alumnae Committee
Jahan Ali, NYC Investment Fund
Jack Ahrens, TGap Ventures
Rajni Aneja, zuChem, Inc.
Sylvia Aruffo, Communication Science
Carole Bellis, Wilson Sonsini
Karen Bixby
Rachel Braun Scherl, Semprae Laboratories
Manny Cho, Aon
Corinne Bright, ONSET Ventures
Kirstie Chadwick, Growth Innovators
Ellen Corenswet, Covington & Burling LLP
Christian Cortis, ATV Capital
Jacqueline Crespo, Cassidy & Associates
Kathleen DeRose, Golden Seeds
Ann Dewitt, Flagship Ventures
Mike Diem, SR One
Ted Driscoll, Claremont Creek Ventures
Teresa Esser, Capital Midwest Fund
Bill Fair, Ajax Ventures
Joan Fallon, Curemark, LLC
Pete Farner, TGap Ventures
Lauren Flanagan, Phenomenelle Angels
Barbara Fox, Avaxia Biologics
Sara Frankel, Consultant
Jennifer Friel Goldstein, Pfizer Venture Investments
Ann Gaddy, Life Science Angels
Gary Gamerman, Seraphim Life Sciences
Jan Garfinkle, Arboretum Ventures
Annette Gilchrist, Midwestern University
Stephanie Grossman, Digital & Media Executive
Elma, Hawkins, Biotechnology Consultant
Diana Hoffman, Hoffman Management Consulting
Karen Hong, ProQuest Investments
Mary Howard, Design Technologies, LLC
Nigel Howard, Covington & Burling LLP
Kef Kasdin, Battelle Ventures
Stephen Kraus, Bessemer Venture Partners
Reid Leonard, Merck & Co., Inc.
Roberta Lee, Manoa Medical, Inc.
Donna Lencki, Geneia
Ellen Lubman, Bristol-Meyers Squibb
Carol Marino, Syngenta Venture Capital
Deborah Mash, Ibogen, Inc.
Patricia Meisner, AdhereTx Corporation
Dan Meyer, Point Judith Capital
Jessica Milner, Covington & Burling
Arikha Moses, The Vertical Group
Catherine Mulligan, William Gallagher Associates
Carol Nacy, Sequella, Inc.
Mike O’Donnell, Wilson Sonsini
Anjali Oberoi, NewSeed Advisors
Jill Osur, Blend Tech Solutions
Catherine Oyler, Johnson & Johnson
Nancy Parenteau, Parenteau BioConsultants, LLC
Ann Partlow, Earthrise Capital
Amy Ravi, ExtendMed
Ingrid Rechtinv, Covington & Burling
Karen Spilizewski, RiverVest Venture Partners
LeAnne Tourtellotte, Illinois Technology Association
Liat Tsoref, Slender Medical Ltd.
Mary Wallace Jaensch, Semprae Laboratories
Sue Washer, Applied Genetic Technologies
Yael Weiss, Merck & Co., Inc.
Patti White, Medical Technology
Gervaise Wilhelm, Closys Corporation
Donna Williams, Ceres Venture Fund
Alex Zisson, Thomas, McNerney & Partners
Diane Zuckerman, Evidence-Based Solutions
Coaching Committee
Milena Adamian, Easton Capital
Jack Ahrens, TGAP Ventures
Jahanara Ali, NYC Investment Fund
Rajni Aneja, ZuChem
Elizabeth Bailey, Commons Capital
Leslie Bane, National Semiconductor
Susan Berland, Consultant
Carlos Berland, Grant Thornton LLP
Anne Marie Biernacki, AdhereTx Corporation
Kevin Bitterman, Polaris Ventures
Rachel Braun Scherl, Semprae Laboratories
A.G. Breitenstein, Humedica
Corinne Bright, ONSET Ventures
Candice Brown Elliot, Nouvoyance Inc.
Mike Bunker, Early Stage Partners
Kerry Burke, Covington & Burling LLP
Chris Byrd, Wilson Sonsini
Amanda Cashin, Alexandria Real Estate Equities
Maria Casini, Guard Dog Brand Development
Vita Cassese, Exigen Capital
Maxine Champion
Terry Chase Hazell, Texas State University
Manny Cho, Aon
Amy Chu, Tiger Advisors LLC
Martha Connolly, Maryland Technology Enterprise Institute
Ellen Corenswet, Covington & Burling LLP
Christian Cortis, ATU Capital
Suzanne Cross, Johnson & Johnson
Cynthia Curtis, CA Technologies
Bruce Deming, Covington & Burling LLP
Camille DeSantis, Guard Dog Brand Development
Ann Dewitt, Flagship Ventures
Brendan Doherty, CA Technologies
Ted Driscoll, LSA Member, Claremont Creek
Suzette Dutch, Triathlon Medical Ventures
Teresa Esser, Capital Midwest Fund II
Lauren Flanagan, Phenomenelle Angels
Carmen Fonda, Venable LLP
Barbara Fox, Avaxia Biologics
Jennifer Friel Goldstein, Pfizer Venture Investments
Andrew Friendly, ATV Capital
Oren Fuerst, Tevel Angels
Angela Garcia-Lopez, Grant Thornton LLP
Megan Gates, Mintz Levin
Judy Giordon, NCIIA
Julie Goonewardene, Purdue Research Foundation
Robert Gottlieb, RMG Associates LLC
Karin Gregory, Furman Gregory Deptula
Colleen Grimm, William Gallagher Associates
Liz Groover
David Guin, Withers Bergman
Cal Hackeman, Grant Thornton LLP
Jessica Hall Harrington, Broadview Ventures
Elma Hawkins, Consultant
Sarah Hoagland, Covington & Burling LLP
Diana Hoffman
Karen Hong, ProQuest Investments
Mary Howard, Design Technologies LLC
Nigel Howard, Covington & Burling LLP
Dave Hsu, Consultant
Eva Jack, MedImmune Ventures
Sven Jacobson, Carrot Capital
Christine Janis, Grant Thornton LLP
Elaine Jones, Pfizer Inc.
Veronica Jordon
Tanya Kanigan
Kef Kasdin, Battelle Ventures
Dr. Hollis Kleinert, KSC Life Science Advisors
Stephan Kraus, Bessemer Venture Partners
Roberta Lee, Manoa Medical
Donna Lencki, Geneia
Ron Lennox, CHL Medical Partners
Emily Leonard, Covington & Burling LLP
Reid Leonard, Merck & Co., Inc.
Scott Levy, Grant Thornton LLP
Emily Levy, Synergy Partners
David Lewandoski, Grant Thornton
Debra Liebert, Domain Associates
Ellen Lubman, Bristol-Meyers Squibb
Joan Lyman
Michael Lytton, Biogen Idec
Rob Mashal, Alinea Pharmaceuticals
Andrea McCormick
Chris Meda, Arxis Biotechnologies
Kevin Mendelsohn, Jumpstart, Inc.
Dan Meyer
Jessica Milner, Covington & Burling LLP
Pat Morand, Southwest Michigan First
Todd Morrill, Bio-Rad Laboratories
Toby Moskovits, Heritage Equity Partners
Catherine Mulligan
Michael Murdoch, Aon
Nalini Murdter
Carol Nichols, vcfo
Dana Ono, VIMAC Ventures LLC
Jill Osur, Blend Tech Solutions
Cat Oyler, Johnson & Johnson
William Paiva, Seven Rosin Funds
Ann Partlow, Earthrise Capital
John Perchorowicz, Triage Masters LLC
Amy Ravi, Extend Med
Lisa Richardson
Carey Roberts, Covington & Burling LLP
Paul Rogers, Covington & Burling LLP
Susan Rohrer, Merck & Co., Inc.
Lisa Russell, Grant Thornton
Mira Sahney
Ginette Serrero, A & G Pharmaceutical
Christy Shaffer, Inspipre Pharmaceuticals
Stefanie Shelley
Emily Sheridan, Alexandria Real Estate Equities
Scarlet Shore, Alexandria Real Estate Equities
Lauren Silverman, Novartis Venture Capital
JC Simabana, SVB Capital
Brenda Simensky, Withers Bergman
Karen Spilizewski, RiverVest Venture Partners
Richard Stuebi, Early Stage Partners
Alison Taunton Rigby, RiboNovix Inc.
Lee Tiedrich, Covington & Burling, LLP
Alison Tjosvold, Grant Thornton LLP
Amy Toro, Covington & Burling LLP
Effie Toshav, Wilson Sonsini
Alexis Traynor Kaplan
Liat Tsoref, Slender Medical
Misti Ushio, Harris & Harris Group Inc
Geeta Vemuri, Quaker BioVentures
Becky Voorheis
Catherine Vorwald, Wexford Science & Technology
Joan Vrtis, Kemeta
Mary Wallace Jaensch, Semprae Laboratories
Yael Weiss, Merck & Co Inc
Patti White
Amy Wildstein, Boldcap Ventures
Donna Williamson, Ceres Venture Fund
Jeff Wu, Covington & Burling LLP
Alex Zisson, Thomas McNerny & Partners
Diane Zuckerman, Evidence-Based Solutions